The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer

被引:46
|
作者
Abbaoui, Besma [1 ,7 ]
Telu, Kelly H. [2 ]
Lucas, Christopher R. [1 ,8 ]
Thomas-Ahner, Jennifer M. [3 ]
Schwartz, Steven J. [3 ,4 ]
Clinton, Steven K. [3 ,5 ]
Freitas, Michael A. [3 ,6 ]
Mortazavi, Amir [3 ,5 ]
机构
[1] Ohio State Univ, Coll Med, Integrated Biomed Sci, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Arts & Sci, Dept Chem, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Food Agr & Environm Sci, Dept Food Sci & Technol, Columbus, OH 43210 USA
[5] Ohio State Univ, Coll Med, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[6] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[7] Parker Food Sci & Technology Bldg,2015 Fyffe Rd, Columbus, OH 43210 USA
[8] N350 Scott Lab, 201W 19th Ave Columbus, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
Cruciferous vegetables; Broccoli; Bladder cancer; Isothiocyanates; Sulforaphane; Erucin; Histone acetylation; Histone phosphorylation; DEACETYLASE INHIBITORS; SULFORAPHANE RETARDS; CURRENT PERSPECTIVES; H1; PHOSPHORYLATION; GENE-EXPRESSION; HDAC INHIBITORS; IN-VITRO; APOPTOSIS; CELLS; EPIGENETICS;
D O I
10.1016/j.jprot.2017.01.013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cruciferous vegetable intake is associated with reduced risk of bladder cancer, yet mechanisms remain unclear. Cruciferous vegetable isothiocyanates (ITCs), namely sulforaphane (SFN) and erucin (ECN), significantly inhibit histone deacetylase (HDAC) activity in human bladder cancer cells representing superficial to invasive biology (59-83% inhibition with 20 AM, 48 h treatment), and in bladder cancer xenografts (59 +/- 3% ECN inhibition). Individual HDACs inhibited by SFN and ECN include HDACs 1, 2, 4 and 6. Interestingly, global acetylation status of histories H3 or H4 remain unaltered. The interplay between HDAC inhibition and modest modulation of AcH3 and AcH4 status is partially explained by decreased histone acetyl transferase activity (48.8 +/- 5.3%). In contrast, a significant decrease in phosphorylation status of all isoforms of histone H1 was observed, concomitant with increased phosphatase PP1f3 and PP2A activity. Together, these findings suggest that ITCs modulate histone status via HDAC inhibition and phosphatase enhancement. This allows for reduced levels of histone H1 phosphorylation, a marker correlated with human bladder cancer progression. Therefore, ITC-mediated inhibition of histone H1 phosphorylation presents a novel direction of research in elucidating epidemiological relationships and supports future food-based prevention strategies. Significance: Collectively, our findings suggest that the cruciferous vegetable isothiocyanates: sulforaphane (SFN) and erucin (ECN), impact histones status in bladder cancer cells by modulating specific HDACs and HATs, and enhancing phosphatase activity, resulting in reduction of historic H1 phosphorylation. These findings are significant due to the fact that our previous work positively correlated historic H1 phosphorylation with bladder cancer carcinogenesis and progression. Therefore, we propose that SFN and ECN may inhibit bladder carcinogenesis via epigenetic modulation of gene expression associated with histone H1 phosphorylation. These efforts may elucidate biomarkers useful in epidemiologic studies related to cruciferous vegetable intake and cancer risk or provide intermediate biomarkers for food-based clinical intervention studies in high-risk cohorts. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [21] Histone Acetylation and Chromatin Pattern in Cancer: A Review
    Blanca, Ana
    Vidal-Jimenez, Alfredo
    Campos, Pablo
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2008, 30 (06): : 340 - 341
  • [22] Histone acetylation and the cell-cycle in cancer
    Wang, CG
    Fu, MF
    Mani, S
    Wadler, S
    Senderowicz, AM
    Pestell, RG
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 : D610 - D629
  • [23] Mitochondria govern histone acetylation in colorectal cancer
    Ohshima, Kenji
    Oi, Ryo
    Nojima, Satoshi
    Morii, Eiichi
    JOURNAL OF PATHOLOGY, 2022, 256 (02): : 164 - 173
  • [24] Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity
    Christopher Bruhn
    Giulia Bastianello
    Marco Foiani
    Communications Biology, 5
  • [25] Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity
    Bruhn, Christopher
    Bastianello, Giulia
    Foiani, Marco
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [26] Histone Deacetylase Inhibitors and Bladder Cancer
    Adam, Rosalyn M.
    JOURNAL OF UROLOGY, 2010, 183 (06): : 2120 - 2121
  • [27] Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer
    Shozu, Kanto
    Kaneko, Syuzo
    Shinkai, Norio
    Dozen, Ai
    Kosuge, Hirofumi
    Nakakido, Makoto
    Machino, Hidenori
    Takasawa, Ken
    Asada, Ken
    Komatsu, Masaaki
    Tsumoto, Kouhei
    Ohnuma, Shin-Ichi
    Hamamoto, Ryuji
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [28] Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer
    Kanto Shozu
    Syuzo Kaneko
    Norio Shinkai
    Ai Dozen
    Hirofumi Kosuge
    Makoto Nakakido
    Hidenori Machino
    Ken Takasawa
    Ken Asada
    Masaaki Komatsu
    Kouhei Tsumoto
    Shin-Ichi Ohnuma
    Ryuji Hamamoto
    Clinical Epigenetics, 2022, 14
  • [29] Histone Deacetylases: A Saga of Perturbed Acetylation Homeostasis in Cancer
    Parbin, Sabnam
    Kar, Swayamsiddha
    Shilpi, Arunima
    Sengupta, Dipta
    Deb, Moonmoon
    Rath, Sandip Kumar
    Patra, Samir Kumar
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (01) : 11 - 33
  • [30] Targeting Histone Acetylation Readers and Writers in Leukemia and Cancer
    Benton, Christopher B.
    Fiskus, Warren
    Bhalla, Kapil N.
    CANCER JOURNAL, 2017, 23 (05): : 286 - 291